| View |
|
DRP-5367-09
|
Cefuroxime (as Axetil)
|
Cefuphil
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
30 June 2029
|
| View |
|
DRP-5421-11
|
Telmisartan
|
Curatel
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Healer's Lab Unit II
|
India
|
Renewal
|
04 August 2024
|
05 August 2029
|
| View |
|
DRP-5463-03
|
Olanzapine
|
Olanzgrand 5
|
5 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Ravian Life Science Pvt. Ltd.
|
India
|
Renewal
|
28 August 2024
|
18 August 2029
|
| View |
|
DRP-5585-02
|
Olanzapine
|
Zilano 5 ODT
|
5 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Jubilant Generics Limited
|
India
|
CLIDP Conversion
|
23 February 2024
|
28 March 2029
|
| View |
|
DRP-5683-12
|
Cefixime
|
Cefiryl
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-5683-13
|
Cefixime
|
CEPRIME
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-5683-22
|
Cefixime
|
Tropsiv
|
20 mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
20 February 2029
|
| View |
|
DRP-5683-24
|
CEFIXIME
|
LUXIME
|
20mg/mL
|
Granules For Suspension (Oral Drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
19 March 2024
|
20 February 2029
|
| View |
|
DRP-5685-11
|
Amlodipine (as Besilate)/ Losartan Potassium
|
Unbranded
|
5 mg/50 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker/Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
19 June 2024
|
28 October 2029
|
| View |
|
DRP-5715-03
|
Irbesartan
|
None
|
300 mg
|
Film-Coated Tablet
|
Angiotensin-2-receptor blocker (ARB)
|
Sanofi Winthrop Industrie-Carbon Blanc
|
France
|
CLIDP Conversion
|
01 March 2024
|
03 May 2027
|
| View |
|
DRP-5716-01
|
Irbesartan
|
None
|
150 mg
|
Film-coated Tablet
|
Angiotensin-2-receptor-blocker (ARB)
|
Sanofi Winthrop Industrie
|
France
|
CLIDP Conversion
|
14 February 2024
|
03 May 2027
|
| View |
|
DRP-5840-02
|
Pantoprazole (as sodium)
|
Pantobloc
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
40 mg Lyophilized Powder for Injection (IV)
|
Shreechem Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 February 2024
|
26 May 2029
|
| View |
|
DRP-5834-07
|
Ceftriaxone (as sodium)
|
Jazeft
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Kyung Dong Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
26 February 2024
|
12 September 2028
|
| View |
|
DRP-5830-05
|
Pantoprazole
|
Centramed
|
40 mg
|
Capsule
|
Proton Pump Inhibitor
|
Interphil Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
26 February 2024
|
09 June 2029
|
| View |
|
DRP-586-02
|
Domperidone
|
Gastromec
|
10 mg
|
Tablet
|
Gastrokinetic ( Prokinetic)
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
19 February 2024
|
17 October 2029
|
| View |
|
DRP-6261-04
|
Pantoprazole (as sodium sesquihydrate)
|
Pantodyme
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Opsonin Pharma Limited
|
Bangladesh
|
CLIDP Conversion
|
03 March 2024
|
09 February 2025
|
| View |
|
DRP-6066-03
|
Pantoprazole (as sodium)
|
Pantostan
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
United Biotech Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 March 2024
|
28 January 2026
|
| View |
|
DRP-5966-25
|
Co-Amoxiclav
|
Kiddymox
|
457 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
31 May 2024
|
27 January 2030
|
| View |
|
DRP-5915-04
|
Ofloxacin + Dexamethasone
|
Oflaz-DM
|
0.3 % w/v / 0.1% w/v
|
Ophthalmic Solution
|
Antibacterial
|
Indiana Ophthalmics LLP
|
India
|
Renewal
|
20 March 2024
|
23 December 2029
|
| View |
|
DRP-6949-05
|
Omeprazole
|
Ulcerate
|
20 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
Kopran Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
14 December 2026
|